tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Salim Syed, 107 are a BUY (74.31%), 37 are a HOLD (25.69%).
Analyst Salim Syed, currently employed at MIZUHO, carries an average stock price target met ratio of 54.2% that have a potential upside of 53.57% achieved within 236 days.
Salim Syed’s has documented 285 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BIIB, Biogen at 21-Nov-2024.
Analyst best performing recommendations are on NKTX (NKARTA ).
The best stock recommendation documented was for NKTX (NKARTA ) at 11/16/2023. The price target of $9 was fulfilled within 53 days with a profit of $6.64 (281.36%) receiving and performance score of 53.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$280
$7.89 (2.90%)
$335
8 days ago
(10-Jan-2025)
8/9 (88.89%)
$17.77 (6.78%)
305
Hold
$298
$25.89 (9.51%)
$333
10 days ago
(08-Jan-2025)
25/27 (92.59%)
$33.79 (12.79%)
703
Sell
$256
$-16.11 (-5.92%)
$335
1 months 8 days ago
(10-Dec-2024)
7/9 (77.78%)
$-19.95 (-7.23%)
593
Buy
$330
$57.89 (21.27%)
$362
1 months 22 days ago
(27-Nov-2024)
10/13 (76.92%)
$50.09 (17.90%)
72
Buy
$380
$107.89 (39.65%)
$345
2 months 6 days ago
(12-Nov-2024)
22/24 (91.67%)
$59.89 (18.71%)
644
Which stock is Salim Syed is most bullish on?
Which stock is Salim Syed is most reserved on?
What Year was the first public recommendation made by Salim Syed?
